eTherapeutics Company

eTherapeutics focuses on the discovery of cancer and degenerative diseases of the nervous system.

Total Funding: 112043919.0
Acquisitions Number: 1
Headquarters: Hanborough, Oxfordshire, United Kingdom
Funding Status: IPO
Employee Number: 11-50
Estimated Revenue: Less than $1M
Investment Stage: N/A
Last Funding Type: Post-IPO Equity
Number Of Exists: Post-IPO Equity
Technology: Biotechnology, Health Care, Medical
Investor Type: Company
Last Funding Date: 2022-09-30
Investors Number: 2.0
Founded Date: 2003-01-01
Industry: Early Drug Development